Won-Seog Kim

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project

Dennis D. Weisenburger, Kerry J. Savage, Nancy L. Harris et al. · Blood · 2011 · 429 citations · Full text

Medicine, Hematology, Oncology +7

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma

Stephen M. Ansell, John Radford, Joseph M. Connors et al. · New England Journal of Medicine · 2022 · 328 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Owen A. O’Connor, Muhıt Özcan, Eric D. Jacobsen et al. · Journal of Clinical Oncology · 2019 · 150 citations · Full text

Medicine, Oncology, Pharmacology +17

The Role of¹⁸F-FDG PET/CT for Initial Staging of Nasal Type Natural Killer/T-Cell Lymphoma: A Comparison with Conventional Staging Methods

Seung Hwan Moon, Suk Kyong Cho, Won-Seog Kim et al. · Journal of Nuclear Medicine · 2013 · 72 citations · Full text

Medicine, Oncology, Hematologic Oncology +13

Mosunetuzumab, a Full-Length Bispecific CD20/CD3 Antibody, Displays Clinical Activity in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NHL): Interim Safety and Efficacy Results from a Phase 1 Study

Lihua E. Budde, Laurie H. Sehn, Sarit Assouline et al. · Blood · 2018 · 59 citations

Medicine, Immunology, Oncology +17